Questions continue surrounding how the Philadelphia Eagles handled Jalen Hurts’ blood clot diagnosis before allowing him to play.
Hurts was initially diagnosed with a superficial blood clot in his left calf while the team was in London.
The Eagles said doctors reviewed the results and determined that remaining active was important and that Hurts could safely play against the Jacksonville Jaguars.
After additional testing following the game, doctors discovered that the condition had become more serious.
Hurts was ultimately diagnosed with deep vein thrombosis as well as bilateral pulmonary emboli, meaning blood clots were found in both lungs.
He is now being treated with blood thinners and is expected to miss the remainder of the season, although doctors say his prognosis is very good and they expect him to make a full recovery.
NFL Commissioner Roger Goodell says the league’s chief medical officer reviewed the Eagles’ handling of the situation and found that established medical protocols were followed.
But the NFL Players Association says it wants a more complete investigation before reaching any final conclusions.
The union says determining exactly what happened is important to making sure players receive the highest level of medical care and protection going forward.
Goodell said the NFL welcomes that review.
At this point, the biggest concern is Jalen’s health.